Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Quotient Ltd (NASDAQ:QTNT)

4.35
Delayed Data
As of Dec 02
 +0.13 / +3.08%
Today’s Change
3.76
Today|||52-Week Range
17.44
-72.81%
Year-to-Date
What Makes Quotient (QTNT) a Strong Sell?
Nov 25 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close4.22
Today’s open4.15
Day’s range4.15 - 4.47
Volume26,477
Average volume (3 months)102,336
Market cap$128.3M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+56.75%
Earnings growth (this year)-41.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+0.62%
P/E ratio--
Price/Sales9.29
Price/Book2.37

Competitors

 Today’s
change
Today’s
% change
TRIBTrinity Biotech PLC-0.03-0.44%
CALACalithera Bioscience...+0.15+4.62%
VRMLVermillion Inc-0.01-1.04%
TRILTrillium Therapeutic...-0.50-6.94%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateFebruary 13, 2017
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$18.5M
Annual profit (last year)-$33.9M
Net profit margin-182.91%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, CEO &
Head-Investor Relations
Paul Cowan
Co-
President
Edward Farrell
Corporate headquarters
Penicuik, Midlothian

Forecasts


Search for Jobs